References
- Sagar S M. Oestrogen modulators and clear ceil carcinoma of vagina. Lancet. 1987; 1: 913
- Horwitz R, Flannery J, Merino M, Viscoli C, Brennan T. Clear cell carcinoma of the vagina and cervix. Incidence, undetected disease, and diethylstilbestrol. Clin Res 1985; 33: 524A
- Herbst A L, Unfelder H, Poskanzer D C. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971; 284: 878–881
- Herbst A L, Cole P, Norusis M J, Welch W R, Scully R H. Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 1979; 135: 876–886
- Jones W B, Koulos J P, Saigo P E, Lewis J L. Clear-cell adenocarcinoma of the lower genital tract: Memorial Hospital 1974–1984. Obstet Gynecol. 1987; 70: 573–577
- Melnick S, Cole P, Anderson D, Herbst A. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. N Engl J Med. 1987; 316: 514–516
- Waggoner S E, Anderson S M, Van Eyck S, Fuller J, Luce M C, Herbst A L. Human papillomavirus detection and p53 expression in clear cell adenocarcinoma of the vagina and cervix. Obstet Gynecol. 1994; 84: 404–408
- Tanaka H, Tabata T, Yanase H. Clear cell adenocarcinoma of the vagina in a young female, treated by combination chemotherapy (local and systemic chemotherapy), complicated with chromosomal abnormality. Obstet Gynecol 1994; 55: 259–264